Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpineFrontier is a private U.S. medical device company focused on spine surgery. The company designs, develops, manufactures, and markets spinal implants and surgical instruments used to treat spinal diseases, with a strategic emphasis on minimally invasive and outpatient procedures. Its core commercial approach is built around its Less Exposure Surgery (LES) philosophy and related product systems marketed under LESspine. SpineFrontier appears to be a revenue-generating commercial-stage business rather than a therapeutic drug developer, so it does not have a traditional biotech clinical pipeline. The company serves spine surgeons and healthcare providers with procedural technologies intended to improve surgical workflow, reduce tissue disruption, and support patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpineFrontier.